活动性癫痫患者COVID-19发病率与病死率
该横断面观察研究纳入1537例符合条件患者,其中21例(1.3%)为活动性癫痫。活动性癫痫患者COVID-19累积发病率高于无癫痫人群,PCR阳性者病死率组间无显著差异;多因素分析显示高血压与癫痫患者死亡相关,年龄和癫痫与住院期间死亡相关。
要点
- 活动性癫痫患者COVID-19累积发病率高于无癫痫人群(1.2% vs 0.5%)。
- 21例活动性癫痫患者中5例(23%)死亡,PCR阳性者病死率组间差异无统计学意义。
- 高血压是活动性癫痫患者死亡的关联因素(OR 2.8,95%CI 1.3-21.6)。
核心结论
- 活动性癫痫患者COVID-19累积发病率更高,癫痫与住院期间死亡相关,高血压与癫痫患者死亡相关。
研究设计与样本
- 横断面观察研究,纳入1537例符合纳入标准的患者,其中21例(1.3%)为活动性癫痫,并设对照组比较累积发病率和病死率。
主要发现
- 活动性癫痫患者COVID-19累积发病率为1.2%(95%CI 0.6-2.4),高于无癫痫人群的0.5%(95%CI 0.5-0.5)。
- 在逆转录PCR阳性患者中,活动性癫痫与无癫痫患者病死率分别为33.3%与8.3%(p=0.266),差异无统计学意义。
- 21例活动性癫痫患者中5例(23%)死亡。
- 多因素分析中,活动性癫痫患者死亡相关因素为高血压(OR 2.8,95%CI 1.3-21.6)。
- 另一模型中,年龄(OR 1.0,95%CI 1.0-1.1)和癫痫(OR 5.1,95%CI 1.3-24.0)与住院期间死亡相关。
临床怎么用
- 对活动性癫痫患者应关注COVID-19感染风险,合并高血压者需重点评估死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This article estimates the incidence and fatality of coronavirus disease 2019 (COVID-19) and identifies potential risk factors for fatality in patients with active epilepsy. METHODS: This is a cross-sectional observational study of patients with active epilepsy and COVID-19. A control group was used to compare the cumulative incidence and case-fatality rate (CFR). The main outcomes of the study were cumulative incidence, defined as number of patients with active epilepsy and COVID-19 admitted to an emergency department divided by the total number of patients with epilepsy at risk, and CFR based on the number of deaths during the enrollment period. Multiple logistic regression analysis was performed to investigate risk factors for fatality in patients with active epilepsy. RESULTS: Of the 1,537 patients who fulfilled the inclusion criteria, 21 (1.3%) had active epilepsy. The cumulative incidence (95% confidence interval [CI]) of COVID-19 in patients with epilepsy was higher (1.2% [0.6-2.4]) compared to the population without epilepsy (0.5% [0.5-0.5]). In reverse transcription PCR-positive patients, there were no significant differences in CFR in patients with active epilepsy compared to patients without epilepsy (33.3% vs 8.3%; p = 0.266). Of the 21 patients with active epilepsy, 5 (23%) died. In multivariate analysis, the factor associated with fatality in patients with active epilepsy was hypertension (odds ratio [OR] 2.8 [95% CI 1.3-21.6]). In another model, age (OR 1.0 [95% CI 1.0-1.1]) and epilepsy (OR 5.1 [95% CI 1.3-24.0]) were associated with fatality during hospitalization. CONCLUSION: COVID-19 cumulative incidence was higher in patients with active epilepsy. Epilepsy was associated with fatality during hospitalization. Hypertension was associated with fatality in patients with epilepsy.
引用
- Cabezudo-García P, Ciano-Petersen NL, Mena-Vázquez N, et al. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology. 2020. PMID: 32554773. doi:10.1212/WNL.0000000000010033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。